Hereditary haemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): Otorhinolaryngological manifestations

Clinical Otolaryngology and Allied Sciences

Volumn 26, Issue 2, 2001, Pages 93-98

  Pau, H ^a,b   Carney, A S ^a   Murty, G E ^a  

^a LEICESTER ROYAL INFIRMARY   (United Kingdom)

^b Countess of Chester Health Park ^*  (United Kingdom)

Author keywords

Hereditary haemorrhagic telangiectasia; Osler Weber Rendu syndrome

Indexed keywords

ANDROGEN; ESTROGEN; PROGESTERONE;

ARTIFICIAL EMBOLISM; AUTOSOMAL DOMINANT DISORDER; CLINICAL FEATURE; EPISTAXIS; INCIDENCE; LASER COAGULATION; PRIORITY JOURNAL; RENDU OSLER WEBER DISEASE; REVIEW; SYMPTOMATOLOGY;

ADMINISTRATION, INTRANASAL; ADMINISTRATION, TOPICAL; CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; CHROMOSOMES, HUMAN, PAIR 12; CHROMOSOMES, HUMAN, PAIR 9; EMBOLIZATION, THERAPEUTIC; ESTROGENS; FEMALE; GENE EXPRESSION; HUMANS; LASER SURGERY; LASERS; MALE; MOLECULAR BIOLOGY; NASAL MUCOSA; OTORHINOLARYNGOLOGIC SURGICAL PROCEDURES; PROGESTERONE; TELANGIECTASIA, HEREDITARY HEMORRHAGIC;

EID: 0035032585     PISSN: 03077772     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2273.2001.00442.x     Document Type: Review

References (78)

1. The natural history of epistaxis in hereditary hemorrhagic telangiectasia
2. Familial epistaxis
3. Hereditary epistaxis
4. Multiple hereditary telangiectasia causing hemorrhage (hereditary hemorrhagic telangiectasia)
5. Rendu-Osler-Weber disease: A triple eponymous title lives on
6. Epistaxis repetes chez un sujet porteur de petits angiomes cutanes et muqueux
7. Epistaxis repetes chez un sujet porteur de petits angiomes cutanes et muqueux
8. On a family form of recurring epistaxis, associated with multiple telangiectases of the skin and mucous membranes
9. On multiple haemorrhagic telangiectases with recurring haemorrhages
10. Multiple hereditary development angiomata (telangiectases) of the skin and mucous membranes associated with recurring haemorrhages
11. Ultrastructure and three-dimensional organisation of the telangiectases of hereditary hemorrhagic telangiectasia
12. Current concept: Hereditary hemorrhagic telangiectasia. Review article
13. Clinical spectrum of hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease)
14. Control of epistaxis in patients with hereditary hemorrhagic telangiectasia
15. A third locus for hereditary haemorrhagic telangiectasia maps to chromosome 12q
16. The importance of atavism in the diagnosis of hereditary hemorrhagic telangiectasia
17. Familial telangiectasia
18. Inherited Abnormalities of the Skin
19. Is the homozygous form of multiple telangiectasia lethal?
20. Hereditary haemorrhagic telangiectasia: A Genetic and bibliograghical study
21. A family reunion: A study of hereditary hemorrhagic telangiectasia
22. Hereditary hemorrhagic telangiectasia (HHT) and HLA
23. A disease locus for hereditary haemorrhagic telangiectasia maps to chromosome 9q33-34
24. A gene for hereditary haemorrhagic telangiectasia maps to chromosome 9q3
25. Linkage of hereditary haemorrhagic telangiectasia to chromosome 9q34 and evidence for locus heterogeneity
26. Genetic heterogeneity in hereditary haemorrhagic telangiectasia
27. Genetic heterogeneity in hereditary haemorrhagic telangiectasia: Possible correlation with clinical phenotype
28. A second locus for hereditary haemorrhagic telangiectasia maps to chromosome 12
29. Glaxo/MRS Young Investigator Medal. Molecular studies on adenosine deaminase deficiency and hereditary haemorrhagic telangiectasia
30. Hereditary haemorrhagic telangiectasia with extensive liver involvement is not caused by either HHT1 or HHT2
31. Von Willebrand's Disease and hereditary hemorrhagic telangiectasia
32. Analysis of the relationship of von Willebrand's Disease (vWD) and hereditary hemorrhagic telangiectasia and identification of a potential Type IIA vWD mutation (I1e865 to Thr)
33. Hormonal management of hereditary hemorrhagic telangiectasia
34. Screening of family members of patients with hereditary hemorrhagic telangiectasia
35. Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease): New insights in pathogenesis, complications and treatment
36. Clinical manifestations of hereditary haemorrhagic telangiectasia
37. Percutaneous embolisation for control of nasal blood circulation
38. Therapeutic percutaneous embolisation in intractable epistaxis
39. Place of embolisation in the treatment of severe epistaxis
40. The role of embolisation in the treatment of severe epistaxis
41. Percutaneous embolisation to control epistaxis in Rendu-Osler-Weber disease
42. Therapeutic embolisation for control of epistaxis in a patient with hereditary haemorrhagic telangiectasia
43. Laser photocoagulation in the care of patients with Osler-Weber-Rendu disease: Operative technique in otolaryngology
44. Retrospective study of the role of the argon laser in the management of epistaxis
45. Endoscopy and KTP 532 laser
46. Treatment of hereditary haemorrhagic telangiectasia by Nd-YAG laser photocoagulation
47. Neodynium-Yag laser intranasal photocoagulation in hereditary haemorrhagic telangiectasia: An update report
48. Fiberoptic bronchoscope and Nd-YAG laser treatment of severe epistaxis from nasal hereditary hemorrhagic telangiectasia and hemangioma
49. Hereditary hemorrhagic telangiectasia: What the otolaryngologist should know
50. Septal dermoplasty for control of nosebleeds in hereditary haemorrhagic telangiectasia
51. Long-term results of dermoplasty in the treatment of hereditary haemorrhagic telangiectasia
52. Management of epistaxis in hereditary hemorrhagic telangiectasia: Review of 80 cases
53. Use of human amniotic membrane in otolaryngologic practice
54. Amniotic graft in the management of severe epistaxis due to hereditary haemorrhagic telangiectasia
55. A new technique using cultured epithelial sheets for the management of epistaxis associated with hereditary haemorrhagic telangiectasia
56. Microvascular free flap in hereditary hemorrhagic telangiectasia
57. The management of severe epistaxis due to hereditary haemorrhagic telangiectasia using regional facial cutaneous flaps
58. Modified Young's procedure for refractory epistaxis due to hereditary hemorrhagic telangiectasia
59. Closure of the nasal cavities in the treatment of refractory hereditary haemorrhagic telangiectasia
60. Histopathological and histochemical studies on atrophic rhinitis
61. Closure of the nostrils in atrophic rhinitis
62. Familial hemorrhagic telangiectasia
63. Use of estrogen in treatment of familial hemorrhagic telangiectasia
64. Anon
65. Long-term treatment of epistaxis with oestrogen
66. Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease): Management of epistaxis in nine patients using systemic hormone therapy
67. Estrogen treatment of hereditary hemorrhagic telangiectasia
68. Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease): An electron microscope study of the vascular lesions before and after therapy with hormones
69. The human respiratory nasal mucosa in females using contraceptive pills: An ultramicroscopic and histochemical study
70. Estrogen and progesterone receptors in hereditary hemorrhagic telangiectasia
71. Letter to the editor: Hereditary hemorrhagic telangiectasia and danazol
72. Local oestrogen for recurrent epistaxis caused by familial telangiectasia: A letter
73. Absence of systemic hormonal effects in an oestradiol diether topically active on the vaginal mucosa
74. Management of epistaxis in Rendu-Osler disease: Is brachy-therapy effective?
75. Vestibular closure with a silastic obturator: An alternative to Young's procedure in bleeding diathesis
76. Pulmonary arteriovenous fistula and hereditary hemorrhagic telangiectasia: A review and report of 35 cases of fistula
77. Age related clinical profile of hereditary haemorrhagic telangiectasia in an epidemiologically recruited population